Showing results (1571-1580 of 2,320) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|February 9, 2016
HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammationNikolaos Papageorgiou, Effimia Zacharia, Emmanuel Androulakis, et al.Expert Opinion on Therapeutic Targets|February 4, 2016
Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisitaMareike Witte, Hiroshi Koga, Takashi Hashimoto, et al.Expert Opinion on Therapeutic Targets|February 11, 2016
Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic painAdalberto MerighiExpert Opinion on Therapeutic Targets|January 20, 2016
Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD)Maria E Laucho-Contreras, Francesca Polverino, Yohannes Tesfaigzi, et al.Expert Opinion on Therapeutic Targets|January 21, 2016
The emerging roles of liver X receptors and their ligands in cancerChin-Yo Lin, Lise-Lotte Vedin, Knut R SteffensenExpert Opinion on Therapeutic Targets|September 29, 2015
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disordersLuca Antonioli, Rocchina Colucci, Carolina Pellegrini, et al.Expert Opinion on Therapeutic Targets|September 3, 2015
Therapeutic targets for polycystic kidney diseasePatricia D WilsonExpert Opinion on Therapeutic Targets|October 1, 2015
Targeting tumor glycolysis by a mitotropic agentShanmugasundaram Ganapathy-KanniappanExpert Opinion on Therapeutic Targets|October 7, 2015
Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapyIbrahim H Sahin, Christine A Iacobuzio-Donahue, Eileen M O'ReillyExpert Opinion on Therapeutic Targets|December 16, 2014
The potential of CXCL5 as a target for liver cancer - what do we know so far?Jinglin Xia, Xiaojing Xu, Peixin Huang, et al.Pageof 232